tiprankstipranks
Godavari Biorefineries Limited (IN:GODAVARIB)
:GODAVARIB
India Market
Want to see IN:GODAVARIB full AI Analyst Report?

Godavari Biorefineries Limited (GODAVARIB) AI Stock Analysis

2 Followers

Top Page

IN:GODAVARIB

Godavari Biorefineries Limited

(GODAVARIB)

Select Model
Select Model
Select Model
Neutral 45 (OpenAI - Gpt-5.6Sol)
Rating:45Neutral
Price Target:
₹235.00
▼(-15.60% Downside)
Action:Reiterated
Date:08/26/26
The score is held back mainly by weak cash-flow quality (negative free cash flow despite improved operations) and very thin profitability. Technicals also show a clear downtrend with bearish momentum, and valuation is pressured by an extremely high P/E with no dividend yield support.
Positive Factors
Strong Revenue Rebound
The sharp revenue recovery indicates renewed demand and improved operating throughput. Sustaining this scale can support better fixed-cost absorption and strengthen the company’s position across bio-based chemicals, ethanol and related products.
Negative Factors
Persistent Negative Free Cash Flow
Negative free cash flow in consecutive years shows that investment and operating requirements continue to consume cash after capital spending. Persistent cash deficits could increase funding needs and constrain the company’s ability to pursue growth independently.
Read all positive and negative factors
Positive Factors
Negative Factors
Strong Revenue Rebound
The sharp revenue recovery indicates renewed demand and improved operating throughput. Sustaining this scale can support better fixed-cost absorption and strengthen the company’s position across bio-based chemicals, ethanol and related products.
Read all positive factors

Godavari Biorefineries Limited (GODAVARIB) vs. iShares MSCI India ETF (INDA)

Godavari Biorefineries Limited Business Overview & Revenue Model

Company Description
Godavari Biorefineries Limited, an Indian company established in Mumbai in 1939, specializes in the production and sale of sugar and a wide array of bio-based products. Its sugar offerings encompass classic, brown, plantation white, and refined va...
How the Company Makes Money
Godavari Biorefineries makes money by converting sugarcane-based feedstocks into a portfolio of saleable products and selling them to industrial and consumer-ingredient customers. Key revenue streams include: (1) Bio-based specialty chemicals/ingr...

Godavari Biorefineries Limited Financial Statement Overview

Summary
Operating performance improved with a strong 2026 revenue rebound and slightly better EBIT/EBITDA margins, and leverage remains moderate. However, profitability is still very thin (net margin ~0.18%) and free cash flow stayed negative in both 2025 and 2026, making cash-flow quality the key financial weakness.
Income Statement
54
Neutral
Balance Sheet
62
Positive
Cash Flow
34
Negative
BreakdownTTMMar 2025Mar 2025
Income Statement
Total Revenue20.13B19.88B18.70B
Gross Profit4.12B3.72B3.14B
EBITDA1.02B1.08B1.12B
Net Income2.25M35.28M-234.15M
Balance Sheet
Total Assets0.0020.52B19.55B
Cash, Cash Equivalents and Short-Term Investments321.53M321.53M122.51M
Total Debt0.005.31B4.90B
Total Liabilities-7.88B12.64B11.73B
Stockholders Equity7.88B7.88B7.82B
Cash Flow
Free Cash Flow238.17M-446.91M-654.94M
Operating Cash Flow936.34M1.24B61.52M
Investing Cash Flow-663.53M-1.66B-687.56M
Financing Cash Flow-257.29M444.35M637.43M

Godavari Biorefineries Limited Peers Comparison

Overall Rating
UnderperformOutperform
Sector (55)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
70
Outperform
₹13.07B12.390.83%16.54%204.63%
66
Neutral
₹10.94B7.380.85%9.30%425.35%
55
Neutral
$6.65B3.83-15.92%6.20%10.91%7.18%
55
Neutral
₹22.09B46.052.23%60.74%
54
Neutral
₹216.47B27.650.47%8.20%29.06%
48
Neutral
₹8.38B-58.08
45
Neutral
₹12.04B7,788.337.00%
* General Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
IN:GODAVARIB
Godavari Biorefineries Limited
235.20
-59.35
-20.15%
IN:ANDHRSUGAR
Andhra Sugars Limited
96.44
21.00
27.84%
IN:DEEPAKNTR
Deepak Nitrite Limited
1,587.10
-152.06
-8.74%
IN:GULPOLY
Gulshan Polyols Limited
175.40
15.65
9.80%
IN:SANSTAR
Sanstar Limited
110.30
16.13
17.13%
IN:GEMAROMA
Gem Aromatics Limited
160.50
-112.10
-41.12%

Godavari Biorefineries Limited Corporate Events

Godavari Biorefineries Faces ₹17 Crore GST Demand Over ENA Supplies
Aug 21, 2026
Godavari Biorefineries Limited has disclosed that it received a show cause notice from the Assistant Commissioner of Central GST, Audit, Belagavi, Karnataka, alleging non-payment of GST on the supply of extra neutral alcohol (ENA) for the period f...
Godavari Biorefineries Publishes Q1 FY2026 Unaudited Results in Newspapers
Aug 7, 2026
Godavari Biorefineries Limited has notified the stock exchanges that it has published its unaudited standalone and consolidated financial results for the quarter ended June 30, 2026. The results have been released through newspaper advertisements ...
Godavari Biorefineries Files Q1 Investor Presentation with Exchanges
Aug 6, 2026
Godavari Biorefineries Limited has submitted an investor presentation for the quarter ended June 30, 2026 to the National Stock Exchange of India and BSE, in line with regulatory disclosure requirements. The presentation, branded under the theme o...
Godavari Biorefineries Files Updated Promoter Group Disclosure with Indian Exchanges
Jul 23, 2026
Godavari Biorefineries Limited has submitted to the Indian stock exchanges the required disclosure under Regulation 31(4) of the SEBI Substantial Acquisition of Shares and Takeovers Regulations for the 2025–26 financial year. The filing prov...
Godavari Biorefineries to Host Q1 FY27 Earnings Call on August 7
Jul 22, 2026
Godavari Biorefineries Limited has scheduled an earnings conference call to discuss its financial and operational performance for the quarter ended June 30, 2026, corresponding to Q1 of FY27. The call will take place at 11:00 AM IST on Friday, Aug...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Aug 26, 2026